Additionally, conventional tumor‐related blood biomarkers, such as carcinoembryonic antigen (CEA) and carbohydrate antigens 19–9 (CA19–9), do not have satisfactory sensitivity for HNSCC detection, especially in the early stages.29 The gene discussed is CEACAM5; the disease is head and neck squamous cell carcinoma.